Sintered electrospun poly(ɛ-caprolactone)-poly(ethylene terephthalate) for drug delivery

Electrospinning has the inherent advantage of being able to achieve molecular mixing of polymers having substantially different melting points. Electrospun poly(e-caprolactone)-poly(ethylene terephthalate) (PCL:PET) capsules are densified by sintering to enable drug encapsulation. Proton and diffusive nuclear magnetic resonance, as well as a selective dissolution, suggest an absence of reaction between the two polymers. Sintering at 100 degrees C successfully densifies 88.89:11.11 and 75:25 PCL:PET blends. Following sintering, the otherwise dense 75:25 composition retains electrospun features and exhibits some "memory" of its previous state. Sintering increases UTS approximately eightfold versus as-spun values for 88.89:11.11 and 75:25. Elongation increases sixfold and twofold and modulus 44- and 69-fold for the 75:25 and 88.89:11.11 samples, respectively. Differential scanning calorimetry suggests a postsintering structure of nanoscale PET dispersed in PCL along the original fiber directions. Selective PCL removal from dense blends shows that fibrous characteristics remain. An internal shish-kebab-like structure is also present in as-spun 75:25 PCL:PET. Water absorption of hydrophobic oil-containing capsules is approximately zero after 49 days. In contrast, hydrophilic (HPI) oils allow substantial water uptake. Unsurprisingly, there is no release of a model drug from the hydrophobic carrier. HPI oil provides linear (zero-order) release inversely proportional to PET from the 88.89:11.11 and 75:25 ratios. (c) 2019 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2019, 136, 47731.